Haeggquist & Eck Announces Investigation of INSYS Therapeutics, Inc.

By | 2017-05-24T20:14:29+00:00 June 30th, 2016|Uncategorized|

Haeggquist & Eck, LLP has commenced an investigation into possible violations of the federal securities laws by certain officers and directors at INSYS Therapeutics, Inc. (“Insys” or the “Company”) (NASDAQ: INSY). Insys is a specialty pharmaceutical company that develops and commercializes supportive care products primarily designed to assist patients with pain management. Insys’s core product and [...]

Comments Off on Haeggquist & Eck Announces Investigation of INSYS Therapeutics, Inc.

Amber Eck and Alreen Haeggquist Receive “AV Preeminent” Ratings

By | 2017-05-24T20:14:43+00:00 June 16th, 2016|Uncategorized|

Haeggquist & Eck partners Amber Eck and Alreen Haeggquist have received “AV Preeminent” ratings by research and lawyers’ information clearinghouse Martindale-Hubbell. AV Preeminent distinctions are the highest peer rating standard Martindale-Hubbell bestows on attorneys. The rating signifies that the attorneys' peers rank them at the highest level of professional excellence for legal knowledge, skills, and [...]

Comments Off on Amber Eck and Alreen Haeggquist Receive “AV Preeminent” Ratings